326 related articles for article (PubMed ID: 32347024)
1. The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond.
Moon JS; Karunakaran U; Suma E; Chung SM; Won KC
Diabetes Metab J; 2020 Apr; 44(2):222-233. PubMed ID: 32347024
[TBL] [Abstract][Full Text] [Related]
2. Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells.
Moon JS; Karunakaran U; Elumalai S; Lee IK; Lee HW; Kim YW; Won KC
J Diabetes Complications; 2017 Jan; 31(1):21-30. PubMed ID: 27662780
[TBL] [Abstract][Full Text] [Related]
3. Rac1-NADPH oxidase signaling promotes CD36 activation under glucotoxic conditions in pancreatic beta cells.
Elumalai S; Karunakaran U; Lee IK; Moon JS; Won KC
Redox Biol; 2017 Apr; 11():126-134. PubMed ID: 27912197
[TBL] [Abstract][Full Text] [Related]
4. Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes.
Lytrivi M; Castell AL; Poitout V; Cnop M
J Mol Biol; 2020 Mar; 432(5):1514-1534. PubMed ID: 31628942
[TBL] [Abstract][Full Text] [Related]
5. The Glucotoxicity Protecting Effect of Ezetimibe in Pancreatic Beta Cells via Inhibition of CD36.
Yoon JS; Moon JS; Kim YW; Won KC; Lee HW
J Korean Med Sci; 2016 Apr; 31(4):547-52. PubMed ID: 27051238
[TBL] [Abstract][Full Text] [Related]
6. CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting.
Karunakaran U; Elumalai S; Moon JS; Won KC
Cells; 2021 Jul; 10(7):. PubMed ID: 34360006
[TBL] [Abstract][Full Text] [Related]
7. Facilitation of fatty acid uptake by CD36 in insulin-producing cells reduces fatty-acid-induced insulin secretion and glucose regulation of fatty acid oxidation.
Wallin T; Ma Z; Ogata H; Jørgensen IH; Iezzi M; Wang H; Wollheim CB; Björklund A
Biochim Biophys Acta; 2010 Feb; 1801(2):191-7. PubMed ID: 19931418
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of fatty acid translocase cluster determinant 36 (CD36), stimulated by hyperglycemia, prevents glucotoxicity in INS-1 cells.
Kim YW; Moon JS; Seo YJ; Park SY; Kim JY; Yoon JS; Lee IK; Lee HW; Won KC
Biochem Biophys Res Commun; 2012 Apr; 420(2):462-6. PubMed ID: 22430143
[TBL] [Abstract][Full Text] [Related]
9. The impairment of glucose-stimulated insulin secretion in pancreatic β-cells caused by prolonged glucotoxicity and lipotoxicity is associated with elevated adaptive antioxidant response.
Fu J; Cui Q; Yang B; Hou Y; Wang H; Xu Y; Wang D; Zhang Q; Pi J
Food Chem Toxicol; 2017 Feb; 100():161-167. PubMed ID: 28027979
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes.
Ly LD; Xu S; Choi SK; Ha CM; Thoudam T; Cha SK; Wiederkehr A; Wollheim CB; Lee IK; Park KS
Exp Mol Med; 2017 Feb; 49(2):e291. PubMed ID: 28154371
[TBL] [Abstract][Full Text] [Related]
11. The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications-Update in Pathogenesis, Treatment and Monitoring.
Puchałowicz K; Rać ME
Cells; 2020 Aug; 9(8):. PubMed ID: 32796572
[TBL] [Abstract][Full Text] [Related]
12. The Exocyst Is Required for CD36 Fatty Acid Translocase Trafficking and Free Fatty Acid Uptake in Skeletal Muscle Cells.
Nakamura NK; Tokunaga DS; Ha HY; Polgar N
Cells; 2022 Aug; 11(15):. PubMed ID: 35954283
[TBL] [Abstract][Full Text] [Related]
13. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
Leiter LA; Lewanczuk RZ
Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
[TBL] [Abstract][Full Text] [Related]
14. CD36 dependent redoxosomes promotes ceramide-mediated pancreatic β-cell failure via p66Shc activation.
Karunakaran U; Elumalai S; Moon JS; Won KC
Free Radic Biol Med; 2019 Apr; 134():505-515. PubMed ID: 30735834
[TBL] [Abstract][Full Text] [Related]
15. Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes.
Prentki M; Madiraju SR
Mol Cell Endocrinol; 2012 Apr; 353(1-2):88-100. PubMed ID: 22108437
[TBL] [Abstract][Full Text] [Related]
16. Glucolipotoxicity: fuel excess and beta-cell dysfunction.
Poitout V; Robertson RP
Endocr Rev; 2008 May; 29(3):351-66. PubMed ID: 18048763
[TBL] [Abstract][Full Text] [Related]
17. Glucotoxicity promotes aberrant activation and mislocalization of Ras-related C3 botulinum toxin substrate 1 [Rac1] and metabolic dysfunction in pancreatic islet β-cells: reversal of such metabolic defects by metformin.
Baidwan S; Chekuri A; Hynds DL; Kowluru A
Apoptosis; 2017 Nov; 22(11):1380-1393. PubMed ID: 28828705
[TBL] [Abstract][Full Text] [Related]
18. Glucolipotoxicity-induced Oxidative Stress is Related to Mitochondrial Dysfunction and Apoptosis of Pancreatic β-cell.
Vela-Guajardo JE; Garza-González S; García N
Curr Diabetes Rev; 2021; 17(5):e031120187541. PubMed ID: 33143630
[TBL] [Abstract][Full Text] [Related]
19. Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice.
Héron-Milhavet L; Haluzik M; Yakar S; Gavrilova O; Pack S; Jou WC; Ibrahimi A; Kim H; Hunt D; Yau D; Asghar Z; Joseph J; Wheeler MB; Abumrad NA; LeRoith D
Endocrinology; 2004 Oct; 145(10):4667-76. PubMed ID: 15231693
[TBL] [Abstract][Full Text] [Related]
20. RACking up ceramide-induced islet β-cell dysfunction.
Kowluru A; Kowluru RA
Biochem Pharmacol; 2018 Aug; 154():161-169. PubMed ID: 29715450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
